GLP-1 medications like Ozempic and Wegovy are used for weight loss and diabetes. Learn how they work, their costs, and potential side effects.

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need to know before July 2026.

Medicare will expand coverage for GLP-1 drugs. Here's how this new development will affect you if you are on Medicare ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

From a surprising eye health finding to screen-time sleep loss and sunscreen secrets, here's what you need to know in health news.

Certain tortillas are now being marketed as ‘GLP-1 friendly.’ What does that even mean? - While a ‘GLP-1 friendly’ label may ...

Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work.

Some patients taking GLP-1 drugs to lose weight or manage Type 2 diabetes are discovering an emerging potential side effect ...

India, May 31 -- Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly ...

Retatrutide, Eli Lilly’s new experimental drug, helped some participants lose up to 28 percent of their body weight in clinical trials.

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...